Financial News
All News about Cel-Sci Corp
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240815767286/en/2216350/22/P3_Study_Population_chart.jpg)
From CEL-SCI Corporation
Via Business Wire
BioMedNewsBreaks — CEL-SCI Corp. (NYSE American: CVM) Closes on $10.8M Best-Efforts Offering
August 02, 2024
Exposures
Product Safety
![](https://mms.businesswire.com/media/20240729532240/en/226967/22/CEL-SCI_Logo.jpg)
CEL-SCI Announces Closing of $10.8 Million Offering
July 29, 2024
From CEL-SCI Corporation
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/25_4.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/07/26/xrdDAFqNaIkdw02-j153520640059868796-t230.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240726229829/en/226967/22/CEL-SCI_Logo.jpg)
CEL-SCI Announces Pricing of $10.8 Million Offering
July 26, 2024
From CEL-SCI Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240726306579/en/2197755/22/CEL-SCI.jpg)
![](https://mms.businesswire.com/media/20240708501317/en/2178861/22/CEL-SCI_Logo_resized.jpg)
From CEL-SCI Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240618624058/en/2162492/5/MKvsControl_graphic_061824.jpg)
![](https://mms.businesswire.com/media/20240606671425/en/2152009/22/CEL-SCI_Survival_graphic.jpg)
![](https://mms.businesswire.com/media/20240516626742/en/226967/22/CEL-SCI_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/08/vaccine-4892059.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240508140076/en/226967/22/CEL-SCI_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240423365855/en/226967/22/CEL-SCI_Logo.jpg)
CEL-SCI Appoints Mario Gobbo to Its Board of Directors
April 23, 2024
From CEL-SCI Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240319610056/en/226967/22/CEL-SCI_Logo.jpg)
![](https://mms.businesswire.com/media/20240304023416/en/226967/22/CEL-SCI_Logo.jpg)
CEL-SCI Corporation Issues Letter to Shareholders
March 06, 2024
From CEL-SCI Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240215017088/en/226967/22/CEL-SCI_Logo.jpg)
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
February 15, 2024
From CEL-SCI Corporation
Via Business Wire
InvestorNewsBreaks – CEL-SCI Corporation (NYSE American: CVM) Closes on $7.75M Public Offering
February 14, 2024
Exposures
Product Safety
![](https://mms.businesswire.com/media/20240213353838/en/226967/22/CEL-SCI_Logo.jpg)
From CEL-SCI Corporation
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
February 09, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240209945546/en/226967/22/CEL-SCI_Logo.jpg)
From CEL-SCI Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240206088192/en/226967/22/CEL-SCI_Logo.jpg)
![](https://mms.businesswire.com/media/20240131910101/en/2014493/5/Figure5.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
December 28, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20231222804784/en/226967/22/CEL-SCI_Logo.jpg)
CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments
December 22, 2023
From CEL-SCI Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.